In addition to DMD, patients with other NMDs, including Fukuyama-type congenital muscular dystrophy (FCMD), dysferlinopathy, and sarcoglycanopathy, also revealed reduced levels of AQP4, although its roles in pathogenesis and pathophysiology are unclear [74]. Here, AQP4 is linked to sarcoglycanopathy.